EBMT 2019 | CAR T-cells and BiTEs for hematological malignancies

Dieter Hoelzer

Dieter Hoelzer, MD, PhD, of the University of Frankfurt, Frankfurt, Germany, discusses CAR T-cell therapy and Bi-specific T-cell engager (BiTEs) bispecific antibodies at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Share this video